PREDICTED: Homo sapiens solute carrier family 2 member 9 (SLC2A9), tra - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.
Highlight Sequence Features
Opens the Highlight Feature Bar and highlights feature annotations from the FEATURES table of the record. The Highlight Feature Bar can be used to navigate to and highlight other features and provides links to display the highlighted region separately. Links in the FEATURES table will also highlight the corresponding region of the sequence. More...
Find in this Sequence
Finds sub-sequences or patterns in the sequence and highlights the matching regions. The tool works with standard single letter nucleotide or protein codes including ambiguities and can match Prosite patterns in protein sequences. More...
Show in Genome Data Viewer
Opens the Genome Data Viewer, NCBI's genome browser, at the genomic location at which this sequence is annotated. View this sequence in the context of other features annotated at the same location and browse to other genome regions.

Raised CK and acute kidney injury following intense exercise in three patients with a history of exercise intolerance due to homozygous mutations in SLC2A9. [Neuromuscul Disord. 2024]
Raised CK and acute kidney injury following intense exercise in three patients with a history of exercise intolerance due to homozygous mutations in SLC2A9.
Quinlivan R, Murphy E, Pula S, Pain A, Brain H, Scopes G, Gjika F, Ahmadouk N, Manole A, Houlden H. Neuromuscul Disord. 2024 Jan; 34:49-53. Epub 2023 Dec 6.
GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study. [J Hum Genet. 2023]
GLUT9 as a potential drug target for chronic kidney disease: Drug target validation by a Mendelian randomization study.
Ueda M, Fukui K, Kamatani N, Kamitsuji S, Matsuo A, Sasase T, Nishiu J, Matsushita M. J Hum Genet. 2023 Oct; 68(10):699-704. Epub 2023 Jun 13.
Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M). [Int J Mol Sci. 2023]
Pathogenic Variants of SLC22A12 (URAT1) and SLC2A9 (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of SLC2A9 Variant c.374C>T; p.(T125M).
Perdomo-Ramirez A, Cordoba-Lanus E, Trujillo-Frias CJ, Gonzalez-Navasa C, Ramos-Trujillo E, Luis-Yanes MI, Garcia-Nieto V, Claverie-Martin F, RenalTube. Int J Mol Sci. 2023 May 8; 24(9). Epub 2023 May 8.

RefSeq alternative splicing
See 53 reference mRNA sequence splice variants for the SLC2A9 gene.
RefSeq protein product
See the reference protein sequence for solute carrier family 2, facilitated glucose transporter member 9 isoform X20 (XP_054206506.1).

BioProject
Related BioProject entry
Protein
Protein sequence from Nucleotide coding region
Taxonomy
Taxonomy sequences associated with Nucleotide record
Annotated Genomic
Genomic sequence records that have the current RNA records as annotated features marking the exons of genes.
BioSystems
BioSystems
Gene
Link to related Genes
PubMed (RefSeq)
Link to RefSeq PubMed articles
PubMed (Weighted)
Links to pubmed

Order SLC2A9 cDNA clone/Protein/Antibody/RNAi [OriGene]
Order SLC2A9 cDNA clone/Protein/Antibody/RNAi
OriGene

PREDICTED: Homo sapiens solute carrier family 2 member 9 (SLC2A9), transcript va...
PREDICTED: Homo sapiens solute carrier family 2 member 9 (SLC2A9), transcript variant X20, mRNA
gi|2462598258|ref|XM_054350531.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide